SecBot SecBot

Treat and Reduce Obesity Act of 2023

H.R. 4818 Rep. Brad Wenstrup (R-OH-2) In committee
  1. Introduced Jul 20
  2. Committee Jul 20
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jul 20, 2023Next: House vote
670d ago Dec 27, 2024: Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-959, Part I.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
5companies, 16 filings
Member trades
7trades in the last 90 days
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

5 companies
Companies by sector
Biotech & Pharma 4Financials 1
Search all 5 companies, their asks and price moves Subscribe

Summary

Treat and Reduce Obesity Act of 2023

Full summary2 paragraphs

This bill expands Medicare coverage of intensive behavioral therapy for obesity. Specifically, the bill allows coverage for therapy that is provided by (1) a physician who is not a primary care physician; or (2) other health care providers (e.g., physician assistants and nurse practitioners) and approved counseling programs, if provided upon a referral from, and in coordination with, a physician or primary care practitioner. Currently, such therapy is covered only if provided by a primary care practitioner.

The bill also allows coverage under Medicare's prescription drug benefit of drugs used for the treatment of obesity or for weight loss management for individuals who are overweight.

Library of Congress summary, Jul 20, 2023

Summary versions
  • Introduced in HouseJul 20, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.